MedTrace Logo

Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

NCT01270971 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 594

Last updated 2019-02-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

Conditions

  • Onychomycosis of Toenails

Interventions

DRUG

AN2690 Topical Solution, 5%

AN2690 Topical Solution, 5%, applied once daily for 48 weeks

DRUG

Solution Vehicle

AN2690 Topical Solution, Vehicle, applied once daily for 48 weeks

Sponsors & Collaborators

Principal Investigators

  • PfizerCT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-01
Primary Completion
2012-11-30
Completion
2013-01-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01270971 on ClinicalTrials.gov